We serve Chemical Name:2-Bromo-5,6-dimethylnicotinonitrile CAS:113124-06-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Bromo-5,6-dimethylnicotinonitrile
CAS.NO:113124-06-4
Synonyms:2-Bromo-5,6-dimethylnicotinonitrile;3-Pyridinecarbonitrile, 2-bromo-5,6-dimethyl-;2-bromo-5,6-dimethylpyridine-3-carbonitrile
Molecular Formula:C8H7BrN2
Molecular Weight:211.059
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:340.1±42.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.582
PSA:36.68000
Exact Mass:209.979248
LogP:2.03
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Bromo-5,6-dimethylnicotinonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-bromo-5,6-dimethylpyridine-3-carbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Pyridinecarbonitrile, 2-bromo-5,6-dimethyl- Use and application,2-Bromo-5,6-dimethylnicotinonitrile technical grade,usp/ep/jp grade.
Related News: The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years. 2-Bromo-5,6-dimethylnicotinonitrile manufacturer Our quality control staff then conducts analyses in the testing laboratory to examine whether the API manufactured is ultrapure. 2-Bromo-5,6-dimethylnicotinonitrile supplier Last month, Emergent Chief Executive Robert Kramer said it was his understanding that there are 100 million doses of J&J’s vaccine ready for FDA review and that regulators had begun the review process. 2-Bromo-5,6-dimethylnicotinonitrile vendor The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years. 2-Bromo-5,6-dimethylnicotinonitrile factory Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.
